{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:28:40Z","timestamp":1791052120247,"version":"4.1.0"},"reference-count":155,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":120,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2001,8,22]]},"abstract":"<jats:p>Oesophageal adenocarcinoma is one of the most deadly human malignancies. Gastro\u2010oesophageal reflux disease (GERD) has been established as a strong risk factor for oesophageal adenocarcinoma, and more than 40% of adult Americans experience regular GERD symptoms. GERD can be complicated by oesophagitis, and by replacement of oesophageal squamous mucosa with metaplastic, intestinal\u2010type epithelium (Barrett\u2019s oesophagus) that is predisposed to malignancy.<\/jats:p><jats:p>Cancers in Barrett\u2019s oesophagus arise through a sequence of genetic alterations which endow unlimited proliferative capacity upon the cells by affecting components of the cell cycle clock apparatus\u2014the pivotal molecular machinery in the cell nucleus that controls whether a cell will proliferate, differentiate, become quiescent or die.<\/jats:p><jats:p>This report describes how the genetic abnormalities that have been recognized in Barrett\u2019s oesophagus might promote carcinogenesis through effects on the cell cycle clock machinery. The goal of this review is to provide the clinician with a useful conceptual basis for evaluating studies on the molecular mechanisms underlying the progression from metaplasia to carcinoma in Barrett\u2019s oesophagus.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2001.01046.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:44:56Z","timestamp":1047354296000},"page":"1087-1100","source":"Crossref","is-referenced-by-count":45,"title":["Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett\u2019s oesophagus"],"prefix":"10.1111","volume":"15","author":[{"given":"R. F.","family":"Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"Spechler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_15_2_2","doi-asserted-by":"crossref","unstructured":"ParkerSL TongT BoldenS WingoPA.Cancer statistics 1997.CA Cancer J Clin199747:5\u201327.","DOI":"10.3322\/canjclin.47.1.5"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.4.1286"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91433-5"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5"},{"key":"e_1_2_15_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.5.584"},{"key":"e_1_2_15_8_2","first-page":"3288","article-title":"Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett\u2019s esophagus","volume":"48","author":"Garewal HS","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90259-4"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119018"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1999.0029900327"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(99)00046-5"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90385-2"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90227-7"},{"key":"e_1_2_15_15_2","first-page":"457","article-title":"Increased expression of the cyclin D1 gene in Barrett\u2019s esophagus","volume":"5","author":"Arber N","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19991215)86:12<2597::aid-cncr3>3.3.co;2-s"},{"key":"e_1_2_15_17_2","first-page":"7021","article-title":"Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon","volume":"60","author":"Lin L","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_15_18_2","first-page":"5766","article-title":"Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers","volume":"51","author":"Boynton RF","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_15_19_2","first-page":"1889","article-title":"Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas","volume":"53","author":"Huang Y","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10434-999-0298-7"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.19.2973"},{"key":"e_1_2_15_22_2","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan MB","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90759-R"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91058-P"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.46.4.330"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90225-9"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(96)90317-2"},{"key":"e_1_2_15_28_2","first-page":"877","article-title":"Analysis of Ki\u201067, 53 and Bcl\u20102 expression in the dysplasia\u2013carcinoma sequence of Barrett\u2019s esophagus","volume":"6","author":"Rioux\u2010Leclercq N","year":"1999","journal-title":"Oncol. Report"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018891923998"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.4976"},{"key":"e_1_2_15_31_2","first-page":"5482","article-title":"17p allelic deletions and p53 protein overexpression in Barrett\u2019s adenocarcinoma","volume":"51","author":"Blount PL","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_15_32_2","first-page":"2292","article-title":"17p allelic losses in diploid cells of patients with Barrett\u2019s esophagus who develop aneuploidy","volume":"54","author":"Blount PL","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/8816"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.8.3221"},{"key":"e_1_2_15_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.14.7081"},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90415-4"},{"key":"e_1_2_15_37_2","first-page":"4495","article-title":"p53 gene mutations in Barrett\u2019s epithelium and esophageal cancer","volume":"51","author":"Casson AG","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_15_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.7.3654"},{"key":"e_1_2_15_39_2","first-page":"3627","article-title":"Induction of cyclin D1 overexpression by activated ras","volume":"9","author":"Filmus J","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_15_40_2","first-page":"402","article-title":"Increased expression of epidermal growth factor receptors in Barrett\u2019s esophagus associated with alkaline reflux: a putative model for carcinogenesis","volume":"88","author":"Jankowski J","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_15_41_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529209165436"},{"key":"e_1_2_15_42_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs0810663"},{"key":"e_1_2_15_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910600103"},{"key":"e_1_2_15_44_2","first-page":"105","article-title":"Transforming growth factor\u2010alpha, epidermal growth factor receptor, and MiB\u20101 expression in Barrett\u2019s\u2010associated neoplasia: correlation with prognosis","volume":"10","author":"Yacoub L","year":"1997","journal-title":"Mod Pathol"},{"key":"e_1_2_15_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-5793(97)00412-2"},{"key":"e_1_2_15_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.8.1033"},{"key":"e_1_2_15_47_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.47.1.23"},{"key":"e_1_2_15_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(00)80195-1"},{"key":"e_1_2_15_49_2","doi-asserted-by":"publisher","DOI":"10.2741\/A331"},{"key":"e_1_2_15_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202171"},{"key":"e_1_2_15_51_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6285471"},{"key":"e_1_2_15_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-419X(81)90003-2"},{"key":"e_1_2_15_53_2","first-page":"3627","article-title":"Activation of c\u2010Ki\u2010ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products","volume":"50","author":"Meltzer SJ","year":"1990","journal-title":"Cancer Res"},{"key":"e_1_2_15_54_2","first-page":"3379","article-title":"Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett\u2019s\u2010associated esophageal adenocarcinomas","volume":"54","author":"Meltzer SJ","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_15_55_2","first-page":"799","article-title":"K\u2010ras point mutations are rare events in premalignant forms of Barrett\u2019s oesophagus","volume":"8","author":"Trautmann B","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_15_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421807"},{"key":"e_1_2_15_57_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910073411510"},{"key":"e_1_2_15_58_2","doi-asserted-by":"publisher","DOI":"10.1038\/37284"},{"key":"e_1_2_15_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19970516)71:4<573::aid-ijc11>3.3.co;2-1"},{"key":"e_1_2_15_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81132-0"},{"key":"e_1_2_15_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-2264(199909)26:1<54::aid-gcc8>3.3.co;2-4"},{"key":"e_1_2_15_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.645"},{"key":"e_1_2_15_63_2","first-page":"2578","article-title":"Frequency of Smad gene mutations in human cancers","volume":"57","author":"Riggins GJ","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_15_64_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7761852"},{"key":"e_1_2_15_65_2","first-page":"5548","article-title":"Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer","volume":"55","author":"Parsons R","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_15_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(97)70217-8"},{"key":"e_1_2_15_67_2","first-page":"320","article-title":"Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers","volume":"59","author":"Grady WM","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_15_68_2","first-page":"263","article-title":"Loss of transforming growth factor\u2010beta type II receptor gene expression in primary human esophageal cancer","volume":"75","author":"Garrigue\u2010Antar L","year":"1996","journal-title":"Lab Invest"},{"key":"e_1_2_15_69_2","first-page":"4351","article-title":"Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma","volume":"56","author":"Barrett MT","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_15_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/366704a0"},{"key":"e_1_2_15_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/371257a0"},{"key":"e_1_2_15_72_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8153634"},{"key":"e_1_2_15_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/368753a0"},{"key":"e_1_2_15_74_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5293.1672"},{"key":"e_1_2_15_75_2","first-page":"1867","article-title":"Allelic loss of 9p21 and mutation of the CDKN2\/p16 gene develop as early lesions during neoplastic progression in Barrett\u2019s esophagus","volume":"13","author":"Barrett MT","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_15_76_2","first-page":"4499","article-title":"Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4","volume":"56","author":"Hammoud ZT","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_15_77_2","first-page":"1873","article-title":"Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms","volume":"12","author":"Barrett MT","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_15_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.607"},{"key":"e_1_2_15_79_2","first-page":"2619","article-title":"p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas","volume":"57","author":"Wong DJ","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_15_80_2","first-page":"3737","article-title":"The MTS1 gene is frequently mutated in primary human esophageal tumors","volume":"9","author":"Zhou X","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_15_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/4.10.1883"},{"key":"e_1_2_15_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0795-686"},{"key":"e_1_2_15_83_2","first-page":"4531","article-title":"Methylation of the 5\u2032 CpG island of the p16\/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing","volume":"55","author":"Gonzalez\u2010Zulueta M","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_15_84_2","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers","volume":"55","author":"Herman JG","year":"1995","journal-title":"Cancer Res"},{"key":"e_1_2_15_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70016-2"},{"key":"e_1_2_15_86_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4644(19960616)61:4<514::aid-jcb4>3.3.co;2-d"},{"key":"e_1_2_15_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80122-6"},{"key":"e_1_2_15_88_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.118.3.703"},{"key":"e_1_2_15_89_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.120.3.757"},{"key":"e_1_2_15_90_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.127.5.1375"},{"key":"e_1_2_15_91_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2631"},{"key":"e_1_2_15_92_2","first-page":"883","article-title":"Dominant negative inhibition of the association between beta\u2010catenin and c\u2010erbB\u20102 by N\u2010terminally deleted beta\u2010catenin suppresses the invasion and metastasis of cancer cells","volume":"13","author":"Shibata T","year":"1996","journal-title":"Oncogene"},{"key":"e_1_2_15_93_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-61107-0_9"},{"key":"e_1_2_15_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4773(96)00597-7"},{"key":"e_1_2_15_95_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.10.12.1443"},{"key":"e_1_2_15_96_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5264.1023"},{"key":"e_1_2_15_97_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.127.6.2061"},{"key":"e_1_2_15_98_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.10.5549"},{"key":"e_1_2_15_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(95)90055-1"},{"key":"e_1_2_15_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81333-1"},{"key":"e_1_2_15_101_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.1185"},{"key":"e_1_2_15_102_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5307.1784"},{"key":"e_1_2_15_103_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5307.1787"},{"key":"e_1_2_15_104_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5307.1790"},{"key":"e_1_2_15_105_2","first-page":"1808","article-title":"E\u2010cadherin expression in gastroesophageal reflux disease, Barrett\u2019s esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study","volume":"90","author":"Swami S","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_15_106_2","first-page":"805","article-title":"Expression of beta\u2010catenin, alpha\u2010catenin, and E\u2010cadherin in Barrett\u2019s esophagus and esophageal adenocarcinomas","volume":"11","author":"Washington K","year":"1998","journal-title":"Mod Pathol"},{"key":"e_1_2_15_107_2","doi-asserted-by":"publisher","DOI":"10.1080\/028418699432635"},{"key":"e_1_2_15_108_2","first-page":"135","article-title":"Altered cadherin and catenin complexes in the Barrett\u2019s esophagus\u2010dysplasia\u2010adenocarcinoma sequence: correlation with disease progression and dedifferentiation","volume":"152","author":"Bailey T","year":"1998","journal-title":"Am J Pathol"},{"key":"e_1_2_15_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90818-4"},{"key":"e_1_2_15_110_2","first-page":"5021","article-title":"Fields of aberrant CpG island hypermethylation in Barrett\u2019s esophagus and associated adenocarcinoma","volume":"60","author":"Eads CA","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_15_111_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.22.1805"},{"key":"e_1_2_15_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90412-3"},{"key":"e_1_2_15_113_2","doi-asserted-by":"publisher","DOI":"10.1038\/385637a0"},{"key":"e_1_2_15_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01291-6"},{"key":"e_1_2_15_115_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.c000258200"},{"key":"e_1_2_15_116_2","first-page":"24965","article-title":"Transcriptional regulation of human prostaglandin\u2010endoperoxide synthase\u20102 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin\u20106 expression site and cAMP response element","volume":"270","author":"Inoue H","year":"1995","journal-title":"Curr Opin Cell Biol"},{"key":"e_1_2_15_117_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.4.1178"},{"key":"e_1_2_15_118_2","first-page":"9049","article-title":"Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines","volume":"268","author":"Jones DA","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"e_1_2_15_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(96)70083-5"},{"key":"e_1_2_15_120_2","first-page":"4245","article-title":"NS398, a selective cyclooxygenase\u20102 inhibitor, induces apoptosis and down\u2010regulates bcl\u20102 expression in LNCaP cells","volume":"58","author":"Liu XH","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_15_121_2","first-page":"1679","article-title":"Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase\u20102 (COX\u20102) \u2013selective nonsteroidal anti\u2010inflammatory drug: independence from COX\u20102 protein expression","volume":"3","author":"Elder DJ","year":"1997","journal-title":"Clin Cancer Res"},{"key":"e_1_2_15_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90127-2"},{"key":"e_1_2_15_123_2","first-page":"32943","article-title":"Ceramide regulates the transcription of cyclooxygenase\u20102. Evidence for involvement of extracellular signal\u2010regulated kinase\/c\u2010June N\u2010terminal kinase and p38 mitogen\u2010activated protein kinase pathways","volume":"273","author":"Subbaramaiah K","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"e_1_2_15_124_2","first-page":"21875","article-title":"Resveratrol inhibits cyclooxygenase\u20102 transcription and activity in phorbol ester\u2010treated human mammary epithelial cells","volume":"273","author":"Subbaramaiah K","year":"1998","journal-title":"Curr Opin Cell Biol"},{"key":"e_1_2_15_125_2","first-page":"1322","article-title":"Aspirin use and risk of fatal cancer","volume":"53","author":"Thun MJ","year":"1993","journal-title":"Cancer Res"},{"key":"e_1_2_15_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70330-0"},{"key":"e_1_2_15_127_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.11.912"},{"key":"e_1_2_15_128_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509073331001"},{"key":"e_1_2_15_129_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281805"},{"key":"e_1_2_15_130_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90411-5"},{"key":"e_1_2_15_131_2","first-page":"4356","article-title":"Increased cyclooxygenase\u20102 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti\u2010inflammatory drugs","volume":"59","author":"Molina MA","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_15_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81988-1"},{"key":"e_1_2_15_133_2","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase\u20102 inhibitor, against colon carcinogenesis","volume":"58","author":"Kawamori T","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_15_134_2","first-page":"362","article-title":"Modulation of apoptosis and Bcl\u20102 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng H","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_15_135_2","first-page":"4566","article-title":"Evaluation of cyclooxygenase\u20102 inhibitor for potential chemopreventive properties in colon carcinogenesis","volume":"56","author":"Reddy BS","year":"1996","journal-title":"Cancer Res"},{"key":"e_1_2_15_136_2","first-page":"2929","article-title":"Increased expression of inducible nitric oxide synthase and cyclooxygenase\u20102 in Barrett\u2019s esophagus and associated adenocarcinomas","volume":"58","author":"Wilson KT","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_15_137_2","first-page":"198","article-title":"Cyclooxygenase\u20102 expression in human esophageal carcinoma","volume":"59","author":"Zimmermann KC","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_15_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70254-X"},{"key":"e_1_2_15_139_2","first-page":"5767","article-title":"Selective inhibition of cyclooxygenase\u20102 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells","volume":"60","author":"Souza RF","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_15_140_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900097"},{"key":"e_1_2_15_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90326-L"},{"key":"e_1_2_15_142_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.169.5.1747"},{"key":"e_1_2_15_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)50076-X"},{"key":"e_1_2_15_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(91)90614-5"},{"key":"e_1_2_15_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1296-1361"},{"key":"e_1_2_15_146_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910570314"},{"key":"e_1_2_15_147_2","first-page":"5571","article-title":"Fas\/APO\u20101 (CD95) is not translocated to the cell membrane in esophageal adenocarcinoma","volume":"57","author":"Hughes SJ","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_15_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5699(97)01115-8"},{"key":"e_1_2_15_149_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.12.5986"},{"key":"e_1_2_15_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5699(97)81663-5"},{"key":"e_1_2_15_151_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1296-1306"},{"key":"e_1_2_15_152_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.10.4521"},{"key":"e_1_2_15_153_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(20000201)88:3<524::aid-cncr5>3.3.co;2-l"},{"key":"e_1_2_15_154_2","doi-asserted-by":"publisher","DOI":"10.1053\/hp.2000.6715"},{"key":"e_1_2_15_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1091-255X(00)80049-9"},{"key":"e_1_2_15_156_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19980815)83:4<652::aid-cncr4>3.3.co;2-4"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01046.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2001.01046.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2001.01046.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:43:08Z","timestamp":1697506988000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2001.01046.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,22]]},"references-count":155,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8,22]]}},"alternative-id":["10.1046\/j.1365-2036.2001.01046.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2001.01046.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,22]]}}}